Differences in the multimodal treatment of gastric cancer: East versus west.
There has been a great deal of interest about varying treatment paradigms of gastric cancer in Eastern and Western countries. Differences in tumor biology, screening initiatives, surgical approach, extent of lymphadenectomy, and neoadjuvant versus adjuvant chemotherapy regimens have been studied and documented in the literature. The purpose of this review is to give an updated report on the current status and management differences in the treatment of gastric cancer between Eastern and Western countries.
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Ashley
A
Russo
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.|Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
Ping
P
Li
Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Vivian E
VE
Strong
D003131:Combined Modality Therapy; D055088:Early Detection of Cancer; D005743:Gastrectomy; D005773:Gastroscopy; D006801:Humans; D010535:Laparoscopy; D008197:Lymph Node Excision; D009367:Neoplasm Staging; D016032:Randomized Controlled Trials as Topic; D013274:Stomach Neoplasms / Q000453:epidemiology / Q000209:etiology / Q000473:pathology / Q000628:therapy*
Eastern; Western; gastric adenocarcinoma; gastric cancer